.Pharmacolibrary.Drugs.R_RespiratorySystem.R03C_AdrenergicsForSystemicUse.R03CC08_Procaterol.Procaterol .Pharmacolibrary.Drugs.R_RespiratorySystem.R03C_AdrenergicsForSystemicUse.R03CC08_Procaterol.Procaterol| name: | Procaterol |
| ATC code: | R03CC08 | route: | oral |
| n-compartments | 1 |
Procaterol is a short-acting selective beta-2 adrenergic agonist used primarily for the treatment of bronchial asthma and chronic obstructive pulmonary disease (COPD). It acts as a bronchodilator. Procaterol is not approved for use in the United States or European Union, but is used in Japan and some other countries.
Pharmacokinetic parameters reported in healthy adult volunteers after oral administration.
Kobayashi, H, et al., & Miyamoto, T (2010). Pharmacokinetic study of the oral administration of procaterol hydrochloride hydrate 50 µg in healthy adult Japanese men. International journal of clinical pharmacology and therapeutics 48(11) 744–750. DOI:10.5414/cpp48744 PUBMED:https://pubmed.ncbi.nlm.nih.gov/20979933